| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.71 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |